Instrument-Agnostic Machine Learning Framework for Accurate Prediction of Functional Groups from Tandem Mass Spectrometry
Abstract Structural elucidation of unknown compounds using tandem mass spectrometry (MS/MS) is an ongoing challenge. Expert chemists will often use common product ion peaks and neutral losses or peak matching software to predict structural aspects from MS/MS spectra, a process which is time consuming and limited by the molecular entries in the database. We introduce an instrument-agnostic machine learning (ML) framework that predicts functional groups directly from MS/MS spectra, eliminating the need for conventional database searches. The ML models are trained on data from different sources, the MassBank of North America (MONA), a public database, and a custom MS/MS database acquired using a single high throughput desorption electrospray ionization (DESI) MS/MS platform to showcase transferability of model predictions independent of instrument acquisition. Additionally, a novel spectral representation is developed for ML use by standardizing the spectra to the precursor ion m/z. We utilized molecular metrics, specifically, average molecular F1 score of 87% (MONA) and 76% (DESI) and average molecular accuracy of 94% (MONA) and 87% (DESI), indicating similar model performance when trained on different databases to validate the ML framework. To further illustrate the robustness and transferability of our ML framework, models trained on DESI-generated data successfully predicted functional groups, using spectral data generated from a blind test set of molecules using two different company laboratories using distinct mass spectrometry instruments (Orbitrap and TOF) operated in positive-ion mode electrospray ionization. We believe that such an approach, where models trained on data from one instrument can reliably make accurate predictions on spectra acquired using different instruments in a database-free manner, will significantly expand the practical applications of ML to mass spectrometry.
Authors
- Prageeth R. Wijewardhane (ORCID: https://orcid.org/0000-0002-9781-3053)
- Shane E. Tichy
- Nicolás M. Morato (ORCID: https://orcid.org/0000-0003-0218-407X)
- Christopher J. Welch (ORCID: https://orcid.org/0000-0002-8899-4470)
- Connor H. Beveridge
- Andreas Kaerner
- Prageeth Wijewardhane
- Matthew Muhoberac
- Jeffrey R. Gilbert (ORCID: https://orcid.org/0009-0005-3032-3411)
- Gaurav Chopra (ORCID: https://orcid.org/0000-0003-0942-7898)
- Li‐Kang Zhang (ORCID: https://orcid.org/0000-0003-3757-8116)
- Douglas D. Richardson (ORCID: https://orcid.org/0000-0001-8488-6758)
- Ayanna Shoulds
Institutions
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Agilent Technologies (United States) (US)
- Eli Lilly (United States) (US)
- Purdue University West Lafayette (US)
- Analytical Engineering (United States) (US)
- Corteva (United States) (US)
- Loxo Oncology at Lilly (United States) (US)
- Purdue University Institute for Cancer Research
Publication Details
- Journal
- Analytical Chemistry
- Published
- 2026-10-18
- DOI
- https://doi.org/10.1021/acs.analchem.5c05945
- Primary Topic
- Mass Spectrometry Techniques and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health
- National Cancer Institute
- National Center for Advancing Translational Sciences